Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Rodgers

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Texas Medicine|May 1, 1995
Prevention is key to combating strokeG P Rodgers
JAMA|April 24, 1991
Recent approaches to the treatment of sickle cell anemiaG P Rodgers
Seminars in Oncology|June 1, 1992
Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experienceG P Rodgers
Bailliere'S Clinical Haematology|June 29, 2000
Pharmacological therapyG P Rodgers
Archives of Internal Medicine|May 1, 1988
Sickle-cell trait and physical training. Evidence for improved fitnessG P Rodgers
Seminars in Hematology|July 1, 1997
Overview of pathophysiology and rationale for treatment of sickle cell anemiaG P Rodgers
Expert Opinion on Investigational Drugs|April 27, 2001
Advances in experimental treatment of beta-thalassaemiaG P Rodgers, Y Saunthararajah
The New England Journal of Medicine|February 1, 1996
Hydroxyurea in sickle cell diseaseA N Schechter, G P Rodgers
British Journal of Haematology|October 1, 1995
Novel treatment options in the severe beta-globin disordersG P Rodgers, E A Rachmilewitz
Analytical Biochemistry|January 31, 1998
In vivo footprinting using N-ethyl,N-nitrosourea: improved resolution of the DNA-protein interactions in the human gamma-globin gene promoter regionI H Kim, G P Rodgers
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Texas Medicine|May 1, 1995
Prevention is key to combating strokeG P Rodgers
JAMA|April 24, 1991
Recent approaches to the treatment of sickle cell anemiaG P Rodgers
Seminars in Oncology|June 1, 1992
Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experienceG P Rodgers
Bailliere'S Clinical Haematology|June 29, 2000
Pharmacological therapyG P Rodgers
Archives of Internal Medicine|May 1, 1988
Sickle-cell trait and physical training. Evidence for improved fitnessG P Rodgers
Seminars in Hematology|July 1, 1997
Overview of pathophysiology and rationale for treatment of sickle cell anemiaG P Rodgers
Expert Opinion on Investigational Drugs|April 27, 2001
Advances in experimental treatment of beta-thalassaemiaG P Rodgers, Y Saunthararajah
The New England Journal of Medicine|February 1, 1996
Hydroxyurea in sickle cell diseaseA N Schechter, G P Rodgers
British Journal of Haematology|October 1, 1995
Novel treatment options in the severe beta-globin disordersG P Rodgers, E A Rachmilewitz
Analytical Biochemistry|January 31, 1998
In vivo footprinting using N-ethyl,N-nitrosourea: improved resolution of the DNA-protein interactions in the human gamma-globin gene promoter regionI H Kim, G P Rodgers
Pageof 11